Miriam Puttini

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Carlo Gambacorti‐Passerini, Laura Antolini, François‐Xavier Mahon et al. · JNCI Journal of the National Cancer Institute · 2011 · 424 citations · Full text

<i>In vitro</i> and <i>In vivo</i> Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells

Miriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli et al. · Cancer Research · 2006 · 368 citations

Hematological Malignancy, Cell Signaling, Ski-606 Activity +13

Inhibition of RET tyrosine kinase by SU5416

Luca Mologni, Elisa Sala, Sara Cazzaniga et al. · Journal of Molecular Endocrinology · 2006 · 54 citations · Full text

Molecular Docking, Thyroid Neoplasia, Signal Transduction +11

NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma

Annamaria Galietta, Rosalind H. Gunby, Sara Redaelli et al. · Blood · 2007 · 40 citations · Full text

Treatment with low dose metformin in patients with peripheral vascular disease

G Montanari, A Bondioli, G Rizzato et al. · Pharmacological Research · 1992 · 32 citations

Thrombosis, Low Dose Metformin, Vascular Disease +8